Response to Improving Adherence to Treatment and Reducing Economic Costs of Hypertension: The Role of Olmesartan-Based Treatment

被引：0
|
作者：
Evan Scullin
机构：
[1] Arbor Pharmaceuticals,
来源：
High Blood Pressure & Cardiovascular Prevention | 2017年 / 24卷 / 4期
关键词：
D O I：
10.1007/s40292-017-0230-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：473 / 474
页数：1
相关论文
共 50 条
  • [21] The important role of genetics in the response to treatment of hypertension
    De Cruz-Benayas, A.
    Perez-Ropero, R.
    Jimenez-Lopez, R.
    De Cruz-Benayas, G.
    Alcalde, I. Ocete
    Alarcon, E.
    Maldonado-Martin, A.
    Gil-Extremera, B.
    JOURNAL OF HYPERTENSION, 2006, 24 : S333 - S334
  • [22] THE ROLE OF ALDOSTERONE IN THE RESPONSE TO TREATMENT OF PRIMARY HYPERTENSION
    WEBER, MA
    DRAYER, JIM
    PURDY, RE
    LARAGH, JH
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1982, 4 (9-10) : 1923 - 1934
  • [23] What strategies do Spanish physicians use for improving treatment adherence in hypertension?
    De la Figuera Von Wichmann, M.
    Márquez Contreras, E.
    Fernandez Fernandez, C.
    Roig Ponsa, L.
    Naval Chamosa, J.
    JOURNAL OF HYPERTENSION, 2006, 24 : S40 - S41
  • [24] Treatment of stage 1 and stage 2 hypertension (HTN) utilizing an olmesartan medoxomil (OM)-based treatment algorithm
    Neutel, J
    Smith, D
    Silfani, T
    Lee, Y
    Weber, M
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 70A - 70A
  • [25] Improving Drug Adherence Using Fixed Combinations Caused Beneficial Treatment Outcomes and Decreased Health-Care Costs in Patients with Hypertension
    Kumagai, Naoto
    Onishi, Katsuya
    Hoshino, Kozo
    Nakamori, Shiro
    Kitai, Tamaki
    Yazu, Takahiro
    Oota, Masahiro
    Ueda, Yuji
    Hiraoka, Naoto
    Okamoto, Shinya
    Yamada, Tomomi
    Dohi, Kaoru
    Nakamura, Mashio
    Ito, Masaaki
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2013, 35 (05) : 355 - 360
  • [26] Reducing the Societal Burden of DepressionA Review of Economic Costs, Quality of Care and Effects of Treatment
    Julie M. Donohue
    Harold Alan Pincus
    PharmacoEconomics, 2007, 25 : 7 - 24
  • [27] Reducing the societal burden of depression - A review of economic costs, quality of care and effects of treatment
    Donohue, Julie M.
    Pincus, Harold Alan
    PHARMACOECONOMICS, 2007, 25 (01) : 7 - 24
  • [28] Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan
    Omboni, Stefano
    Volpe, Massimo
    ADVANCES IN THERAPY, 2019, 36 (02) : 278 - 297
  • [29] The economic costs of jail-based methadone maintenance treatment
    Horn, Brady P.
    Li, Xiaoxue
    Mamun, Saleh
    McCrady, Barbara
    French, Michael T.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2018, 44 (06): : 611 - 618
  • [30] Improving Adherence and Reducing Health Care Costs Through Blister-Packaging: An Economic Model for a Commercially Insured Health Plan
    Borrelli, Eric P.
    Saad, Peter
    Barnes, Nathan E.
    Dumitru, Doina
    Lucaci, Julia D.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2024, 16 : 733 - 745
12345